Schobel Alexander Mark
SEC CIK 1406836 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| AQST | Aquestive Therapeutics, Inc. | Chief Innovation, Tech Off | 984.5K | $44.0K | $429.8K | 7 | 2022-06-08 | 2024-03-15 |
Most active insiders at AQST, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Barber Daniel | Pres, CEO, Dir | — | $1.77M |
| 2 | Jung Cassie | COO | — | $664.6K |
| 3 | Boyd Peter E. | See Remarks | — | $257.3K |
| 4 | TOTH A ERNEST JR | CFO | — | $242.9K |
| 5 | BRAENDER LORI J | Corp. Sec | — | $167.2K |
| 6 | Kraus Carl N | Chief Medical Off | — | $141.9K |
| 7 | Krop Julie | Dir | — | $125.4K |
| 8 | Korczynski Sherry | Chief Commercial Off | — | $111.3K |
| 9 | Cioffi Melina | SVP, Regulatory Affairs | — | $105.5K |
| 10 | Zalewski Thomas A. | CLO | — | — |
Schobel Alexander Mark made no open-market trades at AQST in the last 12 months.
Transactions 7
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| A | 2024-10-02 | 2024-03-09 | AQST | Aquestive Therapeutics, Inc. | Schobel Alexander Mark | Chief Innovation, Tech Off | F - Tax | $4.88 | -9,645 | 980.7K | -1.0% | -$47.1K |
| 2024-03-19 | 2024-03-15 | AQST | Aquestive Therapeutics, Inc. | Schobel Alexander Mark | Chief Innovation, Tech Off | S - Sale | $6.00 | -50.0K | 984.5K | -5% | -$300.0K | |
| 2024-03-12 | 2024-03-08 | AQST | Aquestive Therapeutics, Inc. | Schobel Alexander Mark | Chief Innovation, Tech Off | S - Sale | $5.19 | -25.0K | 1.04M | -2% | -$129.8K | |
| 2024-03-12 | 2024-03-09 | AQST | Aquestive Therapeutics, Inc. | Schobel Alexander Mark | Chief Innovation, Tech Off | F - Tax | $4.88 | -5,895 | 1.03M | -0.6% | -$28.8K | |
| D | 2024-03-11 | 2024-03-07 | AQST | Aquestive Therapeutics, Inc. | Schobel Alexander Mark | Chief Innovation, Tech Off | A - Grant | $0.00 | +82.5K | 1.07M | +8% | $0 |
| 2023-03-09 | 2023-03-09 | AQST | Aquestive Therapeutics, Inc. | Schobel Alexander Mark | Chief Innovation, Tech Off | A - Grant | $0.00 | +100.0K | 982.9K | +11% | $0 | |
| D | 2022-06-10 | 2022-06-08 | AQST | Aquestive Therapeutics, Inc. | Schobel Alexander Mark | Chief Innovation, Tech Off | P - Purchase | $0.96 | +45.9K | 882.9K | +5% | +$44.0K |
Purchase Sale Sale after option exercise All abbreviations